Sana Biotechnology (SANA) Accumulated Expenses (2020 - 2026)

Sana Biotechnology's Accumulated Expenses history runs 7 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• In Q1 2026, Accumulated Expenses fell 77.81% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (down 77.81% YoY), while the FY2025 annual figure was $13.2 million, up 338.27% from the prior year.
• Accumulated Expenses came in at $2.2 million for Q1 2026 at Sana Biotechnology, down from $13.2 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $23.7 million in Q4 2023 to a low of $2.0 million in Q3 2025.
• A 5-year average of $11.6 million and a median of $9.8 million in 2025 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses slumped 87.26% in 2024 and surged 338.27% in 2025, its largest moves.
• Sana Biotechnology's Accumulated Expenses stood at $16.5 million in 2022, then jumped by 44.16% to $23.7 million in 2023, then plunged by 87.26% to $3.0 million in 2024, then surged by 338.27% to $13.2 million in 2025, then plunged by 83.56% to $2.2 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $2.2 million, $13.2 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison